Insights into Gut Dysbiosis: Inflammatory Diseases, Obesity, and Restoration Approaches

被引:11
|
作者
Acevedo-Roman, Andy [1 ]
Pagan-Zayas, Natalia [1 ]
Velazquez-Rivera, Liz I. [1 ]
Torres-Ventura, Aryanne C. [1 ]
Godoy-Vitorino, Filipa [1 ]
机构
[1] Univ Puerto Rico, Microbiol Dept, Med Sci Campus, San Juan, PR 00936 USA
基金
美国国家卫生研究院;
关键词
gut microbiota; obesity; ulcerative colitis; Crohn's disease; Clostridioides difficile; FECAL MICROBIOTA TRANSPLANTATION; ULCERATIVE-COLITIS; METABOLIC SYNDROME; ESCHERICHIA-COLI; PROBIOTICS; COMMUNITY; THERAPY; HEALTH; DIET; COLONIZATION;
D O I
10.3390/ijms25179715
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The gut microbiota is one of the most critical factors in human health. It involves numerous physiological processes impacting host health, mainly via immune system modulation. A balanced microbiome contributes to the gut's barrier function, preventing the invasion of pathogens and maintaining the integrity of the gut lining. Dysbiosis, or an imbalance in the gut microbiome's composition and function, disrupts essential processes and contributes to various diseases. This narrative review summarizes key findings related to the gut microbiota in modern multifactorial inflammatory conditions such as ulcerative colitis or Crohn's disease. It addresses the challenges posed by antibiotic-driven dysbiosis, particularly in the context of C. difficile infections, and the development of novel therapies like fecal microbiota transplantation and biotherapeutic drugs to combat these infections. An emphasis is given to restoration of the healthy gut microbiome through dietary interventions, probiotics, prebiotics, and novel approaches for managing gut-related diseases.
引用
收藏
页数:23
相关论文
共 50 条
  • [31] Dysbiosis in inflammatory bowel diseases: egg, not chicken
    Stange, Eduard F.
    FRONTIERS IN MEDICINE, 2024, 11
  • [32] The Role of Gut Dysbiosis and Potential Approaches to Target the Gut Microbiota in Multiple Sclerosis
    Ladakis, Dimitrios C. C.
    Bhargava, Pavan
    CNS DRUGS, 2023, 37 (02) : 117 - 132
  • [33] The Role of Gut Dysbiosis and Potential Approaches to Target the Gut Microbiota in Multiple Sclerosis
    Dimitrios C. Ladakis
    Pavan Bhargava
    CNS Drugs, 2023, 37 : 117 - 132
  • [34] Gut Microbiota Dysbiosis in Obesity-Linked Metabolic Diseases and Prebiotic Potential of Polyphenol-Rich Extracts
    Anhê F.F.
    Varin T.V.
    Le Barz M.
    Desjardins Y.
    Levy E.
    Roy D.
    Marette A.
    Current Obesity Reports, 2015, 4 (4) : 389 - 400
  • [35] Novel Insights into the Mechanisms of Gut Homing and Antiadhesion Therapies in Inflammatory Bowel Diseases
    Zundler, Sebastian
    Neurath, Markus F.
    INFLAMMATORY BOWEL DISEASES, 2017, 23 (04) : 617 - 627
  • [36] Implication of Obesity and Gut Microbiome Dysbiosis in the Etiology of Colorectal Cancer
    Singh, Samradhi
    Sharma, Poonam
    Sarma, Devojit Kumar
    Kumawat, Manoj
    Tiwari, Rajnarayan
    Verma, Vinod
    Nagpal, Ravinder
    Kumar, Manoj
    CANCERS, 2023, 15 (06)
  • [37] Connecting Female Infertility to Obesity, Inflammation, and Maternal Gut Dysbiosis
    Davis, John S.
    ENDOCRINOLOGY, 2016, 157 (05) : 1725 - 1727
  • [38] Impairment of oocyte quality caused by gut microbiota dysbiosis in obesity
    Shan, Liying
    Fan, Haitao
    Guo, Jing
    Zhou, Heyang
    Li, Fengguo
    Jiang, Zhimin
    Wu, Duo
    Feng, Xinlei
    Mo, Ren
    Liu, Yongbin
    Zhang, Teng
    Zhou, Yang
    GENOMICS, 2024, 116 (05)
  • [39] DYSBIOSIS OF GUT ARCHAEA IN OBESITY RECOVERED AFTER BARIATRIC SURGERY
    Yang, Keli
    Yang, Jia
    Zhang, Jingwan
    Wei, Qichun
    Ng, Siew Chien
    Wang, Hui
    GUT, 2021, 70 : A46 - A46
  • [40] SHARED GUT MICROBIOME DYSBIOSIS IN CROHN'S DISEASE AND OBESITY
    Li, Dalin
    Jacobs, Jonathan
    Liu, Zhenqiu
    Braun, Jonathan
    Targan, Stephan R.
    McGovern, Dermot
    GASTROENTEROLOGY, 2017, 152 (05) : S627 - S628